The progression of Alzheimer's disease
(The Global Deterioration Scale)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
DONATE NOW
Your Alzheimer's donation will help billions live without it.
DONATE NOW
Alzheimer's disease is the most common of a large group of disorders known as "dementias". It is a disease of the brain, characterized by deterioration of thinking ability and of memory, caused by the progressive degeneration of brain cells. The disease also affects mood and emotions, behaviour and one's ability to perform activities of daily living. There is currently no cure for Alzheimer's disease nor can its progression be reversed. However, new treatments that will slow down or even stop the disease are expected within the next five to seven years. Moreover, present treatment options and lifestyle choices can often significantly slow the progression of the disease. Related dementias include Vascular Dementia, Frontotemporal Dementia, Creutzfeldt-Jakob Disease and Lewy body Dementia.
Alzheimer's disease typically follows certain stages which will bring about changes in the person's and family's lives. Because the disease affects each individual differently, the symptoms, the order in which they appear and the duration of each stage vary from person to person. In most cases, the disease progresses slowly, and the symptoms of each stage may overlap, often making the move from one stage to another quite subtle. The duration of the disease is usually seven to ten years but may be much longer in some people.
This document is one in a five-part series on the stages of Alzheimer's disease and is written for the person with the disease, their family and caregivers. This overview provides a summary of the stages and information on end-of-life issues. It also includes a modified Global Deterioration Scale1 (GDS), a tool commonly used by health-care providers to measure the progression of the disease and to classify symptoms often seen at each stage. Detailed information on each of the stages, including suggestions for living with the disease, can be found in four separate companion sheets entitled The Progression of Alzheimer's Disease—Early Stage; Middle Stage; Late Stage; and End of Life. Read more: alzheimer.ca
Science builds for cardiovascular benefits of dairy proteins
The combination of isoleucyl-prolyl-proline (IPP) and valyl-prolyl-proline (VPP) were found to reduce arterial stiffness and enhancing the function of the cells lining blood vessels (endothelial cells) in people with hypertension, according to results published in the European Journal of Clinical Nutrition. Read more: nutraingredients.com
What the World Eats ~~~~~~~~~~~ Cuisine of Kazakhstan
No comments:
Post a Comment